alpha-Galactosidase A/GLA Antibody [DyLight 550]
Novus Biologicals, part of Bio-Techne | Catalog # AF6146L
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot, Immunocytochemistry
Label
DyLight 550 (Excitation = 562 nm, Emission = 576 nm)
Antibody Source
Polyclonal Sheep IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Chinese hamster ovary cell line CHO-derived recombinant human alpha‑Galactosidase A/GLA
Leu32-Leu429
Accession # P06280
Leu32-Leu429
Accession # P06280
Specificity
Detects human alpha‑Galactosidase A/GLA in direct ELISAs.
Clonality
Polyclonal
Host
Sheep
Isotype
IgG
Applications for alpha-Galactosidase A/GLA Antibody [DyLight 550]
Application
Recommended Usage
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: alpha-Galactosidase A/GLA
Alternate Names
Agalsidase alpha, GALA, Melibiase
Gene Symbol
GLA
Additional alpha-Galactosidase A/GLA Products
Product Documents for alpha-Galactosidase A/GLA Antibody [DyLight 550]
Product Specific Notices for alpha-Galactosidase A/GLA Antibody [DyLight 550]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...